Skip to main content Skip to footer

Orexo press releases

Orexo appoints Peter Edman as Chief Scientific Officer

4 October 2011 at 09:00 – Regulatory

Orexo appoints Peter Edman as Chief Scientific Officer

Interim report January-June 2011

10 August 2011 at 08:00 – RegulatoryReportQ2

Interim report January-June 2011

Sublinox (Edluar) approved in Canada

25 July 2011 at 08:00 – Regulatory

Sublinox (Edluar) approved in Canada

Orexo announces addendum to prospectus made public

15 June 2011 at 08:30 – Regulatory

Orexo announces addendum to prospectus made public

Abstral® launches in Canada

14 June 2011 at 14:00 – Regulatory

Abstral® launches in Canada

Report from Orexo AB’s extraordinary shareholders’ meeting, 27 May 2011

27 May 2011 at 13:00 – RegulatoryGeneral Meeting

Report from Orexo AB’s extraordinary shareholders’ meeting, 27 May 2011

Orexo launches underwritten rights issue of MSEK 250

4 May 2011 at 07:16 – Regulatory

Orexo launches underwritten rights issue of MSEK 250

Notice of Extraordinary General Meeting in Orexo

4 May 2011 at 07:16 – RegulatoryGeneral Meeting

Notice of Extraordinary General Meeting in Orexo

Interim report, January-March 2011

4 May 2011 at 07:15 – RegulatoryReportQ1

Interim report, January-March 2011

Orexo AB announces that Robin Wright resigns as CFO

11 April 2011 at 13:00 – Regulatory

Orexo AB announces that Robin Wright resigns as CFO

Report from Orexo AB’s Annual General Meeting, 7 April 2011

7 April 2011 at 20:15 – RegulatoryGeneral Meeting

Report from Orexo AB’s Annual General Meeting, 7 April 2011

Abstral® launched and now available in the United States

4 April 2011 at 14:15 – Regulatory

Abstral® launched and now available in the United States

Notice of Annual General Meeting of Orexo

8 March 2011 at 08:00 – RegulatoryGeneral Meeting

Notice of Annual General Meeting of Orexo

Abstral® approved in Canada

22 February 2011 at 14:30 – Regulatory

Abstral® approved in Canada

Report from Orexo AB’s extraordinary shareholders’ meeting, 16 February 2011

17 February 2011 at 07:00 – RegulatoryGeneral Meeting

Report from Orexo AB’s extraordinary shareholders’ meeting, 16 February 2011

Orexo AB (publ.) - Year-end Report, January to December 2010

16 February 2011 at 08:00 – RegulatoryReportQ4

Orexo AB (publ.) - Year-end Report, January to December 2010

IR & Corporate Communications Director

Lena Wange

Subscribe